CSS LLC/IL - CLOVIS ONCOLOGY INC ownership

CLOVIS ONCOLOGY INC's ticker is CLVS and the CUSIP is 189464100. A total of 158 filers reported holding CLOVIS ONCOLOGY INC in Q4 2021. The put-call ratio across all filers is 1.47 and the average weighting 0.0%.

Quarter-by-quarter ownership
CSS LLC/IL ownership history of CLOVIS ONCOLOGY INC
ValueSharesWeighting
Q4 2021$34,000
-39.3%
12,6000.0%0.00%
-50.0%
Q3 2021$56,000
-23.3%
12,6000.0%0.00%
-33.3%
Q2 2021$73,000
-34.8%
12,600
-21.2%
0.00%
-40.0%
Q1 2021$112,000
-87.7%
16,000
-91.6%
0.01%
-85.7%
Q4 2020$910,000
-17.6%
189,5330.0%0.04%
-32.7%
Q3 2020$1,104,000
-13.8%
189,5330.0%0.05%
-28.8%
Q2 2020$1,280,000
-0.9%
189,533
-6.7%
0.07%
-28.4%
Q1 2020$1,292,000
-46.6%
203,100
-12.6%
0.10%
-23.9%
Q4 2019$2,419,000
+385.7%
232,400
+83.0%
0.13%
+318.8%
Q3 2019$498,000
-54.3%
127,000
+73.3%
0.03%
-49.2%
Q2 2019$1,090,000
+18.9%
73,300
+98.1%
0.06%
+14.5%
Q1 2019$917,000
+168.9%
37,000
+94.7%
0.06%
+139.1%
Q4 2018$341,000
-67.7%
19,000
-47.2%
0.02%
-48.9%
Q3 2018$1,057,000
+484.0%
36,013
+800.3%
0.04%
+462.5%
Q2 2018$181,000
-87.4%
4,000
-85.3%
0.01%
-88.9%
Q1 2018$1,436,000
-57.8%
27,200
-45.6%
0.07%
-57.1%
Q4 2017$3,400,000
-23.3%
50,000
-7.1%
0.17%
-22.2%
Q3 2017$4,432,000
-11.9%
53,800
+0.2%
0.22%
-11.5%
Q2 2017$5,028,000
+18.9%
53,700
-19.1%
0.24%
-3.6%
Q1 2017$4,227,000
+68.1%
66,400
+17.2%
0.25%
+84.7%
Q4 2016$2,515,000
+1097.6%
56,632
+843.9%
0.14%
+1041.7%
Q4 2015$210,0006,0000.01%
Other shareholders
CLOVIS ONCOLOGY INC shareholders Q4 2021
NameSharesValueWeighting ↓
Healthcare Value Capital, LLC 150,000$1,564,0004.60%
Healthcare Value Capital, LLC 100,000$1,043,0003.07%
Palo Alto Investors LP 5,056,286$52,712,0002.90%
HIGHBRIDGE CAPITAL MANAGEMENT LLC 1,328,200$13,848,0001.53%
Ikarian Capital, LLC 513,700$5,355,0000.87%
Pinz Capital Management, LP 207,800$2,166,0000.79%
Leap Investments LP 146,300$1,525,0000.72%
Elk Creek Partners, LLC 574,616$5,990,0000.69%
SECTOR GAMMA AS 408,625$4,260,0000.68%
Artal Group S.A. 1,000,000$10,425,0000.40%
View complete list of CLOVIS ONCOLOGY INC shareholders